Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

34.75p
   
  • Change Today:
      0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 73,412
  • Market Cap: 125.61m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart (19-04-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -113.2% -69.5%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.6 3.8
Pr/Book 2.5  
Latest F'cast
Revenue 8.0% 20.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (17.58) (15.42)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.17 (30.98) (14.48)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 32.71 (22.73) (5.80)p n/a n/a n/a n/a 0.0%
31-Dec-24 40.58 (14.30) (3.22)p n/a n/a n/a n/a 0.0%
31-Dec-25 53.70 n/a (0.70)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Holding(s) in Company 20-Mar-2024 16:52 RNS
Holding(s) in Company 13-Mar-2024 15:05 RNS
LTIP Awards 11-Mar-2024 14:00 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 34.75p
Change Today 0.25p
% Change 0.72 %
52 Week High 48.10
52 Week Low 23.25
Volume 73,412
Shares Issued 361.48m
Market Cap 125.61m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
10.37% above the market average10.37% above the market average10.37% above the market average10.37% above the market average10.37% above the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Income Not Available
Growth
41.28% above the market average41.28% above the market average41.28% above the market average41.28% above the market average41.28% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
17:08 15,000 @ 34.75p
15:38 285 @ 34.99p
14:20 15,000 @ 34.70p
14:20 2 @ 35.00p
14:20 119 @ 34.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page